DI MAIO, VELIA CHIARA
DI MAIO, VELIA CHIARA
Dipartimento di Medicina Sperimentale
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
2022-05-01 Howe, Aym; Rodrigo, C; Cunningham, Eb; Douglas, Mw; Dietz, J; Grebely, J; Popping, S; Sfalcin, Ja; Parczewski, M; Sarrazin, C; de Salazar, A; Fuentes, A; Sayan, M; Quer, J; Kjellin, M; Kileng, H; Mor, O; Lennerstrand, J; Fourati, S; Di Maio, Vc; Chulanov, V; Pawlotsky, J; Harrigan, Pr; Ceccherini-Silberstein, F; Garcia, F
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
2016-09-01 Polilli, E; Cento, V; Restelli, U; CECCHERINI SILBERSTEIN, F; Aragri, M; DI MAIO, Vc; Sciacca, A; Santoleri, F; Fazii, P; Costantini, A; Perno, Cf; Parruti, G
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
2020-01-01 Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini Silberstein, F
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
2020-01-01 Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini-Silberstein, F
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study
2021-09-27 Calvaruso, V; Petta, S; Ferraro, D; La Mantia, C; Gibilaro, G; Reina, G; Di Maio, V; Licata, A; Ceccherini Silberstein, F; Di Marco, V; Craxi, A
Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning
2017-05-09 Cuypers, L; Libin, P; Schrooten, Y; Theys, K; DI MAIO, Vc; Cento, V; Lunar, M; Nevens, F; Poljak, M; CECCHERINI SILBERSTEIN, F; Nowé, A; Van Laethem, K; Vandamme, A
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
2021-01-01 Dietz, J; Di Maio, Vc; de Salazar, A; Merino, D; Vermehren, J; Paolucci, S; Kremer, Ae; Lara, M; Pardo, Mr; Zoller, H; Degasperi, E; Peiffer, K; Sighinolfi, L; Téllez, F; Graf, C; Ghisetti, V; Schreiber, J; Fernández-Fuertes, E; Boglione, L; Muñoz-Medina, L; Stauber, R; Gennari, W; Figueruela, B; Santos, J; Lampertico, P; Zeuzem, S; Ceccherini-Silberstein, F; García, F; Sarrazin, C
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
2018-01-01 Di Maio, Vc; Cento, V; Aragri, M; Paolucci, S; Pollicino, T; Coppola, N; Bruzzone, B; Ghisetti, V; Zazzi, M; Brunetto, M; Bertoli, A; Barbaliscia, S; Galli, S; Gennari, W; Baldanti, F; Raimondo, G; Perno, Cf; Ceccherini-Silberstein, F
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b
2021-01-01 Alkhatib, M; DI MAIO, Vc; De Murtas, V; Polilli, E; Milana, M; Teti, E; Fiorentino, G; Calvaruso, V; Barbaliscia, S; Bertoli, A; Scutari, R; Carioti, L; Cento, V; Santoro, M; Orro, A; Maida, I; Lenci, I; Sarmati, L; Craxì, A; Pasquazzi, C; Parruti, G; Babudieri, S; Milanesi, L; Andreoni, M; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F; Svicher, V; Salpini, R
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018
2018-01-01 Sorbo, Mc; Cento, V; Di Maio, Vc; Howe, Aym; Garcia, F; Perno, Cf; Ceccherini-Silberstein, F
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy
2017-01-01 Cuypers, L; Vrancken, B; Fabeni, L; Marascio, N; Cento, V; DI MAIO, Vc; Aragri, M; Pineda Pena, A; Schrooten, Y; Van Laethem, K; Balog, D; Foca, A; Torti, C; Nevens, F; Perno, Cf; Vandamme, A; CECCHERINI SILBERSTEIN, F
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens
2017-01-01 Cento, V; Nguyen, T; Di Carlo, D; Biliotti, E; Gianserra, L; Lenci, I; DI PAOLO, D; Calvaruso, V; Teti, E; Cerrone, M; Romagnoli, D; Melis, M; Danieli, E; Menzaghi, B; Polilli, E; Siciliano, M; Nicolini, L; Di Biagio, A; Magni, C; Bolis, M; Antonucci, F; DI MAIO, Vc; Alfieri, R; Sarmati, L; Casalino, P; Bernardini, S; Micheli, V; Rizzardini, G; Parruti, G; Quirino, T; Puoti, M; Babudieri, S; D'Arminio Monforte, A; Andreoni, M; Craxì, A; Angelico, M; Pasquazzi, C; Taliani, G; Guedj, J; Perno, Cf; CECCHERINI SILBERSTEIN, F
Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years
2023-09-13 Ranno, S; Coltella, L; Linardos, G; DI MAIO, Vc; Colagrossi, L; Gentile, L; Galeno, E; Ciofi degli Atti Marta, L; Cristaldi, S; Villani, A; Raponi, M; Perno, C; Russo, C
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
2019-01-01 Bellocchi, Mc; Aragri, M; Carioti, L; Fabeni, L; Pipitone, Rm; Brancaccio, G; Sorbo, Mc; Barbaliscia, S; Di Maio, Vc; Bronte, F; Grimaudo, S; Mazzucco, W; Frigeri, F; Cantone, M; Pinto, A; Perno, Cf; Craxì, A; Gaeta, Gb; Di Marco, V; Ceccherini-Silberstein, F
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study
2017-09-18 Cento, V; Aragri, M; Teti, E; Polilli, E; Bertoli, A; Foroghi, L; Barbaliscia, S; DI MAIO, Vc; Pieri, A; Pace Palitti, V; Sarmati, L; Parruti, G; Andreoni, M; Perno, Cf; CECCHERINI SILBERSTEIN, F
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life.
2017-01-01 Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Magni, C; Paolucci, S; Babudieri, S; Siciliano, M; Pasquazzi, C; Ciancio, A; Perno, Cf; CECCHERINI SILBERSTEIN, F; Micheli, V; Troshina, Y; Biliotti, E; Milana, M; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, L; Marenco, S; DI MAIO, Vc; Aragri, M; Pecchioli, A; Bertoli, A; Sarrecchia, C; Macera, M; Coppola, N; Puoti, M; Romagnoli, D; Pellicelli, A; Bonora, S; Novati, S; Baldanti, F; Ghisetti, V; Andreoni, M; Taliani, G; Rizzardini, G; Angelico, M
Partially slotted silicon ring resonator covered with electro-optical polymer
2016-01-01 Steglich, P; Mai, C; Stolarek, D; Lischke, S; Kupijai, S; Villringer, C; Pulwer, S; Heinrich, F; Bauer, J; Meister, S; Knoll, D; Casalboni, M; Schrader, S
Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy
2024-05-09 DI MAIO, Vc; Scutari, R; Forqué Rodríguez, L; Colagrossi, L; Coltella, L; Ranno, S; Linardos, G; Gentile, L; Galeno, E; Chiara Vittucci, A; Pisani, M; Cristaldi, S; Villani, A; Raponi, M; Bernaschi, P; Russo, C; Perno, C
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen
2020-11-01 de Salazar, A; Dietz, J; di Maio, Vc; Vermehren, J; Paolucci, S; Müllhaupt, B; Coppola, N; Cabezas, J; Stauber, Re; Puoti, M; Arenas Ruiz Tapiador, Ji; Graf, C; Aragri, M; Jimenez, M; Callegaro, A; Pascasio Acevedo, Jm; Macias Rodriguez, Ma; Rosales Zabal, Jm; Micheli, V; Garcia Del Toro, M; Téllez, F; García, F; Sarrazin, C; Ceccherini-Silberstein, F
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019
2021-06-01 Rossetti, B; Paglicci, L; Di Maio, Vc; Cassol, C; Barbaliscia, S; Paolucci, S; Bruzzone, B; Coppola, N; Montagnani, F; Micheli, V; Monno, L; Zanelli, G; Santantonio, T; Cuomo, N; Caudai, C; Zazzi, M; Ceccherini-Silberstein, F; On Behalf Of The Hcv Virology Italian Resistance Network Vironet, C
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-mag-2022 | Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals | Howe, Aym; Rodrigo, C; Cunningham, Eb; Douglas, Mw; Dietz, J; Grebely, J; Popping, S; Sfalcin, Ja; Parczewski, M; Sarrazin, C; de Salazar, A; Fuentes, A; Sayan, M; Quer, J; Kjellin, M; Kileng, H; Mor, O; Lennerstrand, J; Fourati, S; Di Maio, Vc; Chulanov, V; Pawlotsky, J; Harrigan, Pr; Ceccherini-Silberstein, F; Garcia, F | Articolo su rivista | |
| 1-set-2016 | Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district | Polilli, E; Cento, V; Restelli, U; CECCHERINI SILBERSTEIN, F; Aragri, M; DI MAIO, Vc; Sciacca, A; Santoleri, F; Fazii, P; Costantini, A; Perno, Cf; Parruti, G | Articolo su rivista | |
| 1-gen-2020 | Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses | Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini Silberstein, F | Articolo su rivista | |
| 1-gen-2020 | Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses | Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini-Silberstein, F | Articolo su rivista | |
| 27-set-2021 | Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study | Calvaruso, V; Petta, S; Ferraro, D; La Mantia, C; Gibilaro, G; Reina, G; Di Maio, V; Licata, A; Ceccherini Silberstein, F; Di Marco, V; Craxi, A | Articolo su rivista | |
| 9-mag-2017 | Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning | Cuypers, L; Libin, P; Schrooten, Y; Theys, K; DI MAIO, Vc; Cento, V; Lunar, M; Nevens, F; Poljak, M; CECCHERINI SILBERSTEIN, F; Nowé, A; Van Laethem, K; Vandamme, A | Articolo su rivista | |
| 1-gen-2021 | Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy | Dietz, J; Di Maio, Vc; de Salazar, A; Merino, D; Vermehren, J; Paolucci, S; Kremer, Ae; Lara, M; Pardo, Mr; Zoller, H; Degasperi, E; Peiffer, K; Sighinolfi, L; Téllez, F; Graf, C; Ghisetti, V; Schreiber, J; Fernández-Fuertes, E; Boglione, L; Muñoz-Medina, L; Stauber, R; Gennari, W; Figueruela, B; Santos, J; Lampertico, P; Zeuzem, S; Ceccherini-Silberstein, F; García, F; Sarrazin, C | Articolo su rivista | |
| 1-gen-2018 | Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? | Di Maio, Vc; Cento, V; Aragri, M; Paolucci, S; Pollicino, T; Coppola, N; Bruzzone, B; Ghisetti, V; Zazzi, M; Brunetto, M; Bertoli, A; Barbaliscia, S; Galli, S; Gennari, W; Baldanti, F; Raimondo, G; Perno, Cf; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2021 | Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b | Alkhatib, M; DI MAIO, Vc; De Murtas, V; Polilli, E; Milana, M; Teti, E; Fiorentino, G; Calvaruso, V; Barbaliscia, S; Bertoli, A; Scutari, R; Carioti, L; Cento, V; Santoro, M; Orro, A; Maida, I; Lenci, I; Sarmati, L; Craxì, A; Pasquazzi, C; Parruti, G; Babudieri, S; Milanesi, L; Andreoni, M; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F; Svicher, V; Salpini, R | Articolo su rivista | |
| 1-gen-2018 | Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018 | Sorbo, Mc; Cento, V; Di Maio, Vc; Howe, Aym; Garcia, F; Perno, Cf; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2017 | Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy | Cuypers, L; Vrancken, B; Fabeni, L; Marascio, N; Cento, V; DI MAIO, Vc; Aragri, M; Pineda Pena, A; Schrooten, Y; Van Laethem, K; Balog, D; Foca, A; Torti, C; Nevens, F; Perno, Cf; Vandamme, A; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-gen-2017 | Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens | Cento, V; Nguyen, T; Di Carlo, D; Biliotti, E; Gianserra, L; Lenci, I; DI PAOLO, D; Calvaruso, V; Teti, E; Cerrone, M; Romagnoli, D; Melis, M; Danieli, E; Menzaghi, B; Polilli, E; Siciliano, M; Nicolini, L; Di Biagio, A; Magni, C; Bolis, M; Antonucci, F; DI MAIO, Vc; Alfieri, R; Sarmati, L; Casalino, P; Bernardini, S; Micheli, V; Rizzardini, G; Parruti, G; Quirino, T; Puoti, M; Babudieri, S; D'Arminio Monforte, A; Andreoni, M; Craxì, A; Angelico, M; Pasquazzi, C; Taliani, G; Guedj, J; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 13-set-2023 | Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years | Ranno, S; Coltella, L; Linardos, G; DI MAIO, Vc; Colagrossi, L; Gentile, L; Galeno, E; Ciofi degli Atti Marta, L; Cristaldi, S; Villani, A; Raponi, M; Perno, C; Russo, C | Articolo su rivista | |
| 1-gen-2019 | NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients | Bellocchi, Mc; Aragri, M; Carioti, L; Fabeni, L; Pipitone, Rm; Brancaccio, G; Sorbo, Mc; Barbaliscia, S; Di Maio, Vc; Bronte, F; Grimaudo, S; Mazzucco, W; Frigeri, F; Cantone, M; Pinto, A; Perno, Cf; Craxì, A; Gaeta, Gb; Di Marco, V; Ceccherini-Silberstein, F | Articolo su rivista | |
| 18-set-2017 | Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study | Cento, V; Aragri, M; Teti, E; Polilli, E; Bertoli, A; Foroghi, L; Barbaliscia, S; DI MAIO, Vc; Pieri, A; Pace Palitti, V; Sarmati, L; Parruti, G; Andreoni, M; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-gen-2017 | Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. | Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Magni, C; Paolucci, S; Babudieri, S; Siciliano, M; Pasquazzi, C; Ciancio, A; Perno, Cf; CECCHERINI SILBERSTEIN, F; Micheli, V; Troshina, Y; Biliotti, E; Milana, M; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, L; Marenco, S; DI MAIO, Vc; Aragri, M; Pecchioli, A; Bertoli, A; Sarrecchia, C; Macera, M; Coppola, N; Puoti, M; Romagnoli, D; Pellicelli, A; Bonora, S; Novati, S; Baldanti, F; Ghisetti, V; Andreoni, M; Taliani, G; Rizzardini, G; Angelico, M | Articolo su rivista | |
| 1-gen-2016 | Partially slotted silicon ring resonator covered with electro-optical polymer | Steglich, P; Mai, C; Stolarek, D; Lischke, S; Kupijai, S; Villringer, C; Pulwer, S; Heinrich, F; Bauer, J; Meister, S; Knoll, D; Casalboni, M; Schrader, S | Intervento a convegno | |
| 9-mag-2024 | Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy | DI MAIO, Vc; Scutari, R; Forqué Rodríguez, L; Colagrossi, L; Coltella, L; Ranno, S; Linardos, G; Gentile, L; Galeno, E; Chiara Vittucci, A; Pisani, M; Cristaldi, S; Villani, A; Raponi, M; Bernaschi, P; Russo, C; Perno, C | Articolo su rivista | |
| 1-nov-2020 | Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen | de Salazar, A; Dietz, J; di Maio, Vc; Vermehren, J; Paolucci, S; Müllhaupt, B; Coppola, N; Cabezas, J; Stauber, Re; Puoti, M; Arenas Ruiz Tapiador, Ji; Graf, C; Aragri, M; Jimenez, M; Callegaro, A; Pascasio Acevedo, Jm; Macias Rodriguez, Ma; Rosales Zabal, Jm; Micheli, V; Garcia Del Toro, M; Téllez, F; García, F; Sarrazin, C; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-giu-2021 | Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019 | Rossetti, B; Paglicci, L; Di Maio, Vc; Cassol, C; Barbaliscia, S; Paolucci, S; Bruzzone, B; Coppola, N; Montagnani, F; Micheli, V; Monno, L; Zanelli, G; Santantonio, T; Cuomo, N; Caudai, C; Zazzi, M; Ceccherini-Silberstein, F; On Behalf Of The Hcv Virology Italian Resistance Network Vironet, C | Articolo su rivista |